Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Trkulja

Showing results (81-90 of 145) with videos related to

Pageof 15
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 20, 2020
ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidoneLana Ganoci, Vladimir Trkulja, Maja Živković, et al.
British Journal of Clinical Pharmacology|November 15, 2021
DPYD polymorphisms c.496A>G, c.2194G>A and c.85T>C and risk of severe adverse drug reactions in patients treated with fluoropyrimidine-based protocolsNada Božina, Ivan Bilić, Lana Ganoci, et al.
Medical Hypotheses|August 25, 2019
Elevated plasma RANTES in fibrodysplasia ossificans progressiva - A novel therapeutic target?Lovorka Grgurević, Ruđer Novak, Vladimir Trkulja, et al.
Pharmacogenetics and Genomics|August 5, 2024
The reduced function allele SLCO1B1 c.521T>C is of no practical relevance for the renal graft function over the first post-transplant year in patients treated with mycophenolic acidSandra Nađ Škegro, Luka Penezić, Livija Šimičević, et al.
British Journal of Neurosurgery|July 22, 2025
Spinal dural arteriovenous fistulae: Treatments and outcomes a systematic review and meta-analysisHrvoje Barić, Vladimir Trkulja, Sergio Garcia Garcia, et al.
The Pharmacogenomics Journal|May 20, 2024
Inosine monophosphate dehydrogenase type 2 polymorphism IMPDH2 3757T>C (rs11706052) and 12-month evolution of the graft function in renal transplant recipients on mycophenolate-based immunosuppressionLuka Penezić, Sandra Nađ-Škegro, Ayla Hadžavdić, et al.
Toxics|April 27, 2026
ABCG2 Genetic Variability in Drug Exposure and Toxicity: Implications for Clinical PracticeTamara Božina, Livija Šimičević, Lana Ganoci, et al.
Minerva Anestesiologica|June 12, 2023
Prediction of unfavorable outcomes in community-acquired bacteremia by SIRS, SOFA and qSOFA scoresMarija Kusulja, Vladimir Trkulja, Elizabeta Skočibušić, et al.
Pharmacogenomics|June 16, 2026
Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantationLuka Penezić, Sandra Nađ Škegro, Lana Ganoci, et al.
Croatian Medical Journal|July 2, 2021
Plasma levels of soluble TGF ß receptor type III: no apparent promise as a marker in acute pancreatitisGrgur Salai, Marko Zelenika, Stela Hrkač, et al.
Pageof 15

Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 20, 2020
ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidoneLana Ganoci, Vladimir Trkulja, Maja Živković, et al.
British Journal of Clinical Pharmacology|November 15, 2021
DPYD polymorphisms c.496A>G, c.2194G>A and c.85T>C and risk of severe adverse drug reactions in patients treated with fluoropyrimidine-based protocolsNada Božina, Ivan Bilić, Lana Ganoci, et al.
Medical Hypotheses|August 25, 2019
Elevated plasma RANTES in fibrodysplasia ossificans progressiva - A novel therapeutic target?Lovorka Grgurević, Ruđer Novak, Vladimir Trkulja, et al.
Pharmacogenetics and Genomics|August 5, 2024
The reduced function allele SLCO1B1 c.521T>C is of no practical relevance for the renal graft function over the first post-transplant year in patients treated with mycophenolic acidSandra Nađ Škegro, Luka Penezić, Livija Šimičević, et al.
British Journal of Neurosurgery|July 22, 2025
Spinal dural arteriovenous fistulae: Treatments and outcomes a systematic review and meta-analysisHrvoje Barić, Vladimir Trkulja, Sergio Garcia Garcia, et al.
The Pharmacogenomics Journal|May 20, 2024
Inosine monophosphate dehydrogenase type 2 polymorphism IMPDH2 3757T>C (rs11706052) and 12-month evolution of the graft function in renal transplant recipients on mycophenolate-based immunosuppressionLuka Penezić, Sandra Nađ-Škegro, Ayla Hadžavdić, et al.
Toxics|April 27, 2026
ABCG2 Genetic Variability in Drug Exposure and Toxicity: Implications for Clinical PracticeTamara Božina, Livija Šimičević, Lana Ganoci, et al.
Minerva Anestesiologica|June 12, 2023
Prediction of unfavorable outcomes in community-acquired bacteremia by SIRS, SOFA and qSOFA scoresMarija Kusulja, Vladimir Trkulja, Elizabeta Skočibušić, et al.
Pharmacogenomics|June 16, 2026
Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantationLuka Penezić, Sandra Nađ Škegro, Lana Ganoci, et al.
Croatian Medical Journal|July 2, 2021
Plasma levels of soluble TGF ß receptor type III: no apparent promise as a marker in acute pancreatitisGrgur Salai, Marko Zelenika, Stela Hrkač, et al.
Pageof 15